Successful Use of Lower-Level Laser Therapy in the Treatment of Medication-Related Osteonecrosis of the Jaw
Journal of Lasers in Medical Sciences,
Vol. 8 No. 4 (2017),
27 September 2017
,
Page 201-203
Abstract
Case Presentation: This study aimed to report a case of medication related osteonecrosis of the jaw (MRONJ) of a 65-year-old female patient referred to the Oral and Maxillofacial Surgery team from Araçatuba Dental School, complaining about mobility of a previously dental implant placed on the posterior maxillary region. Clinical examination revealed an extensive necrosis area around the implant region. The patient reported bisphosphonate therapy with sodium alendronate for prevention of osteoporosis 5 years ago. A diagnosis of MRONJ was reached and the treatment decided was to remove the dental implant damaged and use the lower-level laser therapy (LLLT) associated with antibiotic therapy with clindamycin 300 mg and mouth rinses with chlorhexidine 0.12%.Conclusion: Six months after the treatment with LLLT a complete healing of the affected area was observed and 12 months after treatment the patient was rehabilitated with fixed dental prosthesis and showed excellent tissue healing of the necrosis areas. It was concluded that the use of LLLT showed to be a good option in the treatment of MRONJ.
- Laser therapy
- osteonecrosis of the jaw
- biphosphonates
- antiresorptive drugs
How to Cite
References
Svejda B, Muschitz C, Gruber R, et al. Position paper on medication-related osteonecrosis of the jaw (MRONJ) (German). Wien Med Wochenschr. 2016;166(1-2):68-74. doi:10.1007/s10354-016-0437-2.
Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-- 2014 update. J Oral Maxillofac Surg. 2014;72(10):1938- 1956. doi:10.1016/j.joms.2014.04.031
Weber JB, Camilotti RS, Ponte ME. Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review. Lasers Med Sci. 2016;31(6):1261-1272. doi:10.1007/s10103- 016-1929-4.
Khan A, Morrison A, Cheung A, Hashem W, Compston J. Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015. Osteoporos Int. 2016;27(3):853-859. doi:10.1007/ s00198-015-3335-3.
de-Freitas NR, Lima LB, de-Moura MB, Veloso-Guedes CC, Simamoto-Júnior PC, de-Magalhães D. Bisphosphonate treatment and dental implants: A systematic review. Med Oral Patol Oral Cir Bucal. 2016;21(5):e644-e651.
Ruggiero SL. An office-based approach to the diagnosis and management of osteonecrosis. Atlas Oral Maxillofac Surg Clin North Am. 2013;21(2):167-173. doi:10.1016/j. cxom.2013.05.004.
Vescovi P, Manfredi M, Merigo E, et al. Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up. Photomed Laser Surg. 2012;30(1):5-13. doi:10.1089/pho.2010.2955.
- Abstract Viewed: 1306 times
- PDF Downloaded: 779 times
- PDF Downloaded: 329 times